NorthStar Asset Management (Pennsylvania)’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $334K | Hold |
750
| – | – | 0.08% | 119 |
|
|
2025
Q1 | $364K | Hold |
750
| – | – | 0.09% | 115 |
|
|
2024
Q4 | $302K | Hold |
750
| – | – | 0.07% | 123 |
|
|
2024
Q3 | $349K | Hold |
750
| – | – | 0.08% | 121 |
|
|
2024
Q2 | $352K | Hold |
750
| – | – | 0.09% | 115 |
|
|
2024
Q1 | $314K | Hold |
750
| – | – | 0.08% | 127 |
|
|
2023
Q4 | $305K | Hold |
750
| – | – | 0.08% | 122 |
|
|
2023
Q3 | $261K | Hold |
750
| – | – | 0.08% | 128 |
|
|
2023
Q2 | $264K | Sell |
750
-2
| -0.3% | -$704 | 0.07% | 128 |
|
|
2023
Q1 | $237K | Buy |
752
+2
| +0.3% | +$630 | 0.07% | 131 |
|
|
2022
Q4 | $217K | Hold |
750
| – | – | 0.07% | 133 |
|
|
2022
Q3 | $217K | Hold |
750
| – | – | 0.07% | 131 |
|
|
2022
Q2 | $211K | Buy |
+750
| New | +$211K | 0.07% | 129 |
|
|
2020
Q4 | – | Sell |
-750
| Closed | -$204K | – | 138 |
|
|
2020
Q3 | $204K | Hold |
750
| – | – | 0.07% | 123 |
|
|
2020
Q2 | $218K | Buy |
+750
| New | +$218K | 0.08% | 117 |
|